Case report: High-grade serous tubo-ovarian carcinoma with FGFR2::IQCG fusion and insights into targetability

By sjmartinez • January 6, 2025

Sono R, Konecny GE, Zhang L. Case report: High-grade serous tubo-ovarian carcinoma with FGFR2::IQCG fusion and insights into targetability. Front Oncol. 2024 Dec 20;14:1514471. doi: 10.3389/fonc.2024.1514471. PMID: 39759134; PMCID: PMC11695219.

Tags: Case report, FGFR2, FGFR2::IQGC, Hematology/Oncology, high-grade serous tubo-ovarian cancer, novel fusion, Publications

The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia

O'Connor TE, Lin C, Roloff GW, Zhang A, Miller K, Aldoss I, Kopmar NE, Dekker SE, Gupta VK, Jeyakumar N, Muhsen IN, Valtis Y, Ahmed[...]

Isolated Lesion of Penile Kaposi Sarcoma in an HIV-Negative Male Patient

Eeraveni A, Gates G, Singh A, Ahronowitz I. Isolated Lesion of Penile Kaposi Sarcoma in an HIV-Negative Male Patient. Cureus. 2025 Jul 21;17(7):e88451. doi: 10.7759/cureus.88451.[...]

Intermediate endpoints as surrogates for long term outcomes in breast cancer adjuvant chemotherapy trials

Blasco A, López-Tarruella S, Urruticoechea A, Carrasco E, Spera G, Martín M, Bermejo B, Chap L, Ruiz-Borrego M, Crown J, García-Saenz JA, Chan A, Guerrero-Zotano[...]